Journalists and conflicts of interest in science: Beliefs and practices

Ethics in Science and Environmental Politics

Volumn 9, Issue 1, 2009, Pages 33-40

  Cook, Daniel M ^a   Boyd, Elizabeth A ^b   Grossmann, Claudia ^c   Bero, Lisa A ^c  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corporate funding; Financial ties; Print media; Research ethics; Science journalism

Indexed keywords

MASS MEDIA; RESEARCH;

NORTH AMERICA; UNITED STATES;

EID: 65549105967     PISSN: None     EISSN: 16118014     Source Type: Journal    
DOI: 10.3354/esep00100     Document Type: Article

References (47)

1. Ancker JS, Flanagin A (2007) A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 13:147-157
2. Baltimore D (1989) The worsening climate for biological research: is the public losing faith in science? Technology Review 92:22 and 24
3. Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454-465
4. Berman EP (2008) Why did universities start patenting? Institution-building and the Road to the Bayh-Dole Act. Soc Stud Sci 38:835-871
5. Bero LA (2005) Tobacco industry manipulation of research. Public Health Rep 120:200-208
6. Bero L, Oostvogel F, Bacchetti P, Lee K (2007) Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med 4:e184
7. Boffey PM, Rodgers JE, Schneider SH (1999) Interpreting uncertainty: a panel discussion. In: Friedman SM, Dunwoody S, Rogers CL (eds) Communicating uncertainty: media coverage of new and controversial science. Lawrence Erlbaum Associates, Nahwah, NJ
8. Bok D (2003) Universities in the marketplace: the commercialization of higher education. Princeton University Press, Princeton, NJ
9. Boyd EA, Bero LA (2000) Assessing faculty financial relationships with industry. JAMA 284:2209-2214
10. Boyd EA, Cho MK, Bero LA (2003) Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med 78:769-774
11. Campbell P (2001) Declaration of financial interests. Nature 412:751
12. Campbell EG, Powers JB, Blumenthal D, Biles B (2004) Inside the triple helix: technology transfer and commercialization in the life sciences. Health Aff (Millwood) 23:64-76
13. Campbell EG, Weissman JS, Ehringhaus S, Rao SR, Moy B, Feibelmann S, Goold SD (2007) Institutional academic industry relationships. JAMA 298:1779-1786
14. Canales MK, Breslau ES, Nelson DE, Ballard-Barbash RR (2008) Did news reporters get it right? Translation of the 2002 hormone study findings. Am J Prev Med 34:61-68
15. Caulfield T (2004) The Commercialisation of medical and scientific reporting. PLoS Med 1:e38
16. Cho MK, Shohara R, Schissel A, Rennie D (2000) Policies on faculty conflicts of interest at US universities. JAMA 284: 2203-2208
17. Clark F, Illman DL (2006) A longitudinal study of the New York Times Science Times section. Science Communication 27:496-513
18. Cook DM, Boyd EA, Grossmann C, Bero LA (2007) Reporting science and conflicts of interest in the lay press. PLoS One 2:e1266
19. Cooper RJ, Gupta M, Wilkes MS, Hoffman JR (2006) Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med 21: 1248-1252
20. Dana J, Loewenstein G (2003) A social science perspective on gifts to physicians from industry. JAMA 290:252-255
21. Drazen JM, Koski G (2000) To protect those who serve [editorial]. N Engl J Med 343:1643-1645
22. Friedman PJ (2002) The impact of conflict of interest on trust in science. Sci Eng Ethics 8:413-420
23. Geller G, Bernhardt BA, Gardner M, Rodgers J, Holtzman NA (2005) Scientists' and science writers' experiences reporting genetic discoveries: toward an ethic of trust in science journalism. Genet Med 7:198-205
24. Hochman M, Hochman S, Bor D, McCormick D (2008) News media coverage of medication research: reporting pharmaceutical company funding and use of generic medication names. JAMA 300:1544-1550
25. Hyde J (2006) News coverage of genetic cloning: when science journalism becomes future-oriented speculation. J Commun Inq 30:229-250
26. Kennedy D (2004) Disclosure and disinterest. Science 303:15
27. Kua E, Reder M, Grossel MJ (2004) Science in the news: a study of reporting genomics. Public Underst Sci 13: 309-322
28. Kuriya B, Schneid EC, Bell CM (2008) Quality of pharmaceutical industry press releases based on original research. PLoS One 3:e2828
29. Lenzer J (2008) Truly independent research? BMJ 337:a1332
30. Lenzer J, Brownlee S (2008) Naming names: is there an (unbiased) doctor in the house? BMJ 337:a930
31. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS (2007) Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 4:e5
32. Lexchin J, Bero L, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167-1170
33. McInerney C, Bird N, Nucci M (2004) The flow of scientific knowledge from lab to the lay public: the case of genetically modified food. Sci Commun 26:44-74
34. Moynihan R, Sweet M (2000) Medicine, the media and monetary interests: the need for transparency and professionalism. Med J Aust 173:631-634
35. Moynihan R, Bero L, Ross-Degnan D, Henry D and others (2000) Coverage by the news media of the benefits and risks of medications. N Engl J Med 342:1645-1650
36. Pellechia MG (1997) Trends in science coverage: a content analysis ofthree US newspapers. Public Underst Sci 6: 49-68
37. Phillips DP, Kanter EJ, Bednarczyk B, Tastad PL (1991) Importance of the lay press in the transmission of medical knowledge to the scientific community. N Engl J Med 325:1180-1183
38. Rosenstock L, Lee LJ (2002) Attacks on science: the risks to evidence-based policy. Am J Public Health 92:14-18
39. Schwartz LM, Woloshin S, Moynihan R (2008) Who's watching the watchdogs? BMJ 337:a2535
40. Schwitzer G (2008) How do US journalists cover treatments, tests, products, and procedures? An evaluation of 500 stories. PLoS Med 5:e95
41. Singh J, Hallmayer J, Illes J (2007) Interacting and paradoxical forces in neuroscience and society. Nat Rev Neurosci 8:153-160
42. Smith KC, Wakefield MA, Terry-McElrath Y, Chaloupka FJ and others (2008) Relation between newspaper coverage of tobacco issues and smoking attitudes and behaviour among American teens. Tob Control 17: 17-24
43. Stocking SH, Holstein LW (2009) Manufacturing doubt: journalists' roles and the construction of ignorance in a scientific controversy. Public Underst Sci 18:23-42
44. Tereskerz PM, Moreno J (2005) Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. Account Res 12:139-155
45. Washburn J (2005) University, Inc.: The corporate corruption of American higher education. Basic Books, New York
46. Winsten JA (1985) Science and the media: the boundaries of truth. Health Aff 4:5-23
47. Woloshin S, Schwartz LM (2002) Press releases: translating research into news. JAMA 287:2856-2858